IL6 and acute respiratory distress syndrome: When comparing biomarkers between COVID-19 patients who developed ARDS to those not requiring ICU treatment, progranulin and interleukin-6 were the only biomarkers to differ significantly (p < 0.001) on the day of admission to the hospital (see Additional file 1: Table S11).